• Associate Investigator, CanSERV project (https://www.canserv.eu/services/disease-models/): initative no. 1.34_ISS (“Microfluidic Devices generation”), no. 1.32_ISS (“Generation of organoids”) and no. 1.33_ISS (“Tumor-on-chip analysis”); 1 September 2022 - 31 August 2025.

​

• Associate investigator, project HEALTH ITALIA - "Health Extended Alliance for Innovative Therapies, Advanced Lab-Research and Integrated Approaches of Precision Medicine"(2023-2026, funded under the PNRR rules, Spoke 7, Task 1.3).

​

• Associate investigator, "Rome Technopole Foundation" (2022-2025, funded under the PNRR rules, project no. 3277, "Ecosistemi dell'Innovazione", Mission 4 "Istruzione e Ricerca", Component 2, Investment 1.5).

​

• Co-investigator for the AIRC Project (Italian Association for Cancer Research) n. 21366 (2018-2023) entitled "Exploring the antitumoral functions of IL-33-induced eosinophils for improving chemoimmunothrapy against melanoma" (Principal Investigator: Dr. Giovanna Schiavoni).

​

• Co-Proponent of a project under the 2018 Current Research Call entitled "Microenvironment and development of Melanoma: role of exosomes secreted by Dermal Mesenchymal Stem Cells.", Funded by the Ministry of Health, “Ricerca Corrente” (years 2019-2021).

​

• Principal Investigator of the “Progetto Ordinario di Ricerca Finalizzata” n. RF-2011-02347120 entitled "Cell-on-chip technology as a novel tool to investigate the crosstalk between cancer and immune cells: role of the transcription factors Interferon Regulatory Factor 1 and 8 (IRF-1, IRF-8) in melanoma as a model system ”funded by the Italian Ministry of Health (years 2014-2018).

​

• Experimental manager in the context of an experimental mission "Synchrotron Light Laboratory Experimental Proposal n. 20100096 "(November 2010) entitled" Study of the IR spectral profiles in live B16-F10 melanoma tumor cells treated with epigenetic drugs. ", Carried out at Elettra Sincrotrone Trieste, Area Science Park (Basovizza, Trieste, Italy).

​

• Co-Investigator for the AIRC project (Italian Association for Cancer Research) n. 10720 (2010-2012) entitled "Understanding and exploiting Type I IFN antitumor immune mechanisms for development of novel cancer therapies".

​

• Co-Invetigator project AIRC (Italian Association for Cancer Research) n. 4919 (2010-2012) entitled "Understanding type I IFN antitumor immune mechanisms for development of cancer immunotherapy strategies".

​

• Co-Investigator for the AIRC project (Italian Association for Cancer Research) n. 14297 (2013-2016) entitled "Dissecting IL-33 / ST2-dependent pathways in antitumor immune response to melanoma" (Principal Investigator: Dr. Giovanna Schiavoni).

​

• Co-Investigator for the AIRC project (Italian Association for Cancer Research) n. 11610 (2011-2014) entitled "Control of direct and immune-mediated antitumor activities of IRF-8 by epigenetic drugs in colorectal cancer".

​

• Co-investigator (Deliverable Manager) of the European Project n. 200732 (2008-2012) entitled "HOMITB - Host and Mycobacterial Molecular Dissection of Immunity and Pathogenesis of Tuberculosis." (7th Framework Program).

​

• Co-investigator (Deliverable Manager) of the European Project n. 018736 (2005-2008) entitled "NEOTIM - Innate and adaptive immunity in clinical and experimental mycobacterial infection in neonates and infants" (6th Framework Program).

​

• Co-investigator (Deliverable Manager) of the European Project n. QLK2-CT-2002-00846 (2002-2005) entitled: "INNATE DEFENSE - Experimental and clinical dissection of innate immunity against intracellular pathogens" (5th Framework Program).

​

​